Multimodal neural fusion distinguishes tissue states in a small preclinical imaging cohort
Source check: Source checked. Not independent scientific confirmation.
Finding: A two-branch neural network combined Raman spectra and optical-coherence images to distinguish dysplasia/cancer from control tissue. Animal-separated evaluation in a small longitudinal cohort reported 92.3% pooled accuracy. This is preclinical feasibility, not clinical diagnostic accuracy.
Technology: Multimodal convolutional neural network; ResNet-18; Grad-CAM
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Learned spectral and image representations are fused for the specific pathology-reference classification.
- Test and result
- Fivefold animal-independent evaluation used 196 paired observations from 11 mice. Every contributing animal was withheld once.
- Limitation / still unknown
- Small exploratory cohort; early-stopping validation partition is incompletely specified. Measurements used externally positioned tissue rather than deployed endoscopy. Pooled and fold-average metrics differ. No human screening, earlier diagnosis or treatment benefit is demonstrated.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://advanced.onlinelibrary.wiley.com/doi/abs/10.1002/advs.202522344
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 21 Nov 2026. Review scope: Primary front tuple and safe computational fusion/evaluation Methods and nonactionable classification Results; animal procedures excluded..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.